GlassScriptPhysician profile
Sendasaperumal Sendos
NPI 1861717423
$3,298.42
in general payments reported to CMS, 2019-2025
10 companies · $917 in 2025
The $917 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $119 · 2021: $130 · 2022: $367 · 2023: $801 · 2024: $642 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,359.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $1,551.34 | 2019-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Boston Scientific Corporation | $727.75 | 2023-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Administration Set |
| Siemens Medical Solutions USA, INC. | $467.43 | 2021-2024 | |
| Ethicon US, LLC | $148.77 | 2023 | Neuwave |
| Penumbra, INC. | $134.88 | 2025 | Pod |
| Ge Healthcare | $116.01 | 2019 | |
| Cook Medical LLC | $83.79 | 2019 | |
| Trisalus Life Sciences, INC. | $49.07 | 2025 | Trinav Infusion System |
| Medtronic USA, INC. | $19.38 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$871,281.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sendasaperumal Sendos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.